| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
RESEARCH COMMUNICATION |
a The Center for Experimental Therapeutics, Pathology and Laboratory Medicine, University of Pennsylvania, School of Medicine. Philadelphia, Pennsylvania, 19104, USA
b Center for Neurodegenerative Disease Research, Pathology and Laboratory Medicine, University of Pennsylvania, School of Medicine. Philadelphia, Pennsylvania, 19104, USA
c Claude Pepper Institute and Department of Chemistry, Florida Institute of Technology, Melbourne, Florida 32901, USA
Alzheimer's disease (AD) includes a group of dementing neurodegenerative disorders that have diverse etiologies but the same hallmark brain lesions. Since oxidative stress may play a role in the pathogenesis of AD and isoprostanes are chemically stable peroxidation products of arachidonic acid, we measured both iPF2
-III and iPF2 -VI using gas chromatography-mass spectrometry in AD and control brains. The levels of both isoprostanes, but not of 6-keto PGF1, an index of prostaglandin production, were markedly elevated in both frontal and temporal poles of AD brains compared to the corresponding cerebella. Levels were also elevated compared to corresponding areas of brains from patients who had died with schizophrenia or Parkinson's disease or from nonneuropsychiatric disorders. iPF2 -IV, but not iPF2-III, levels were higher in ventricular CSF of AD brains relative to the non-AD brains. These data suggest that specific isoprostane analysis may reflect increased oxidative stress in AD.—Praticò, D., Lee, V. M.-Y., Trojanowski, J. Q., Rokach, J., FitzGerald, G. A. Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. FASEB J. 12, 1777–1783 (1998)
Key Words: oxidative stress • schizophrenia • temporal lobes • neurofibrillary tangles
This article has been cited by other articles:
|
|
 |
|
  D. W. Shineman, B. Zhang, S. N. Leight, D. Pratico, and V. M.-Y. Lee Thromboxane Receptor Activation Mediates Isoprostane-Induced Increases in Amyloid Pathology in Tg2576 Mice J. Neurosci., April 30, 2008; 28(18): 4785 - 4794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Firuzi, J. Zhuo, C. M. Chinnici, T. Wisniewski, and D. Pratico 5-Lipoxygenase gene disruption reduces amyloid-{beta} pathology in a mouse model of Alzheimer's disease FASEB J, April 1, 2008; 22(4): 1169 - 1178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-L. Song, J. A. Lawson, D. Reilly, J. Rokach, C.-T. Chang, B. Giasson, and G. A. FitzGerald Neurofurans, Novel Indices of Oxidant Stress Derived from Docosahexaenoic Acid J. Biol. Chem., January 4, 2008; 283(1): 6 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q.-L. Ma, B. Teter, O. J. Ubeda, T. Morihara, D. Dhoot, M. D. Nyby, M. L. Tuck, S. A. Frautschy, and G. M. Cole Omega-3 Fatty Acid Docosahexaenoic Acid Increases SorLA/LR11, a Sorting Protein with Reduced Expression in Sporadic Alzheimer's Disease (AD): Relevance to AD Prevention J. Neurosci., December 26, 2007; 27(52): 14299 - 14307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. V. J. Murray, L. Liu, H. Komatsu, K. Uryu, G. Xiao, J. A. Lawson, and P. H. Axelsen Membrane-mediated Amyloidogenesis and the Promotion of Oxidative Lipid Damage by Amyloid beta Proteins J. Biol. Chem., March 30, 2007; 282(13): 9335 - 9345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Forman, E. J. Mufson, S. Leurgans, D. Pratico, S. Joyce, S. Leight, V. M.-Y. Lee, and J. Q. Trojanowski Cortical biochemistry in MCI and Alzheimer disease: Lack of correlation with clinical diagnosis Neurology, March 6, 2007; 68(10): 757 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J DE LEON, L MOSCONI, K BLENNOW, S DESANTI, R ZINKOWSKI, P. D MEHTA, D PRATICO, W TSUI, L. A. S. LOUIS, L SOBANSKA, et al. Imaging and CSF Studies in the Preclinical Diagnosis of Alzheimer's Disease Ann. N.Y. Acad. Sci., February 1, 2007; 1097(1): 114 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Watson Thematic review series: Systems Biology Approaches to Metabolic and Cardiovascular Disorders. Lipidomics: a global approach to lipid analysis in biological systems J. Lipid Res., October 1, 2006; 47(10): 2101 - 2111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Zhan, P. Fenik, D. Pratico, and S. C. Veasey Inducible Nitric Oxide Synthase in Long-term Intermittent Hypoxia: Hypersomnolence and Brain Injury Am. J. Respir. Crit. Care Med., June 15, 2005; 171(12): 1414 - 1420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. J. Johnson, S.-H. Kim, and R. P. Sharma Aluminum-Maltolate Induces Apoptosis and Necrosis in Neuro-2a Cells: Potential Role for p53 Signaling Toxicol. Sci., February 1, 2005; 83(2): 329 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. KONTUSH and S. SCHEKATOLINA Vitamin E in Neurodegenerative Disorders: Alzheimer's Disease Ann. N.Y. Acad. Sci., December 1, 2004; 1031(1): 249 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. MONTUSCHI, P. J. BARNES, and L. J. ROBERTS II Isoprostanes: markers and mediators of oxidative stress FASEB J, December 1, 2004; 18(15): 1791 - 1800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Silakova, J. A. Hewett, and S. J. Hewett Naproxen Reduces Excitotoxic Neurodegeneration in Vivo with an Extended Therapeutic Window J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1060 - 1066. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sanchez-Moreno, J. F. Dashe, T. Scott, D. Thaler, M. F. Folstein, and A. Martin Decreased Levels of Plasma Vitamin C and Increased Concentrations of Inflammatory and Oxidative Stress Markers After Stroke Stroke, January 1, 2004; 35(1): 163 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Irizarry and B. T. Hyman Brain isoprostanes: A marker of lipid peroxidation and oxidative stress in AD Neurology, August 26, 2003; 61(4): 436 - 437. [Full Text] [PDF]
|
|
|
|
|
|
Y. Yao, V. Zhukareva, S. Sung, C.M. Clark, J. Rokach, V.M.-Y. Lee, J.Q. Trojanowski, and D. Pratico Enhanced brain levels of 8,12-iso-iPF2{alpha}-VI differentiate AD from frontotemporal dementia Neurology, August 26, 2003; 61(4): 475 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Clark and J. H.T. Karlawish Alzheimer Disease: Current Concepts and Emerging Diagnostic and Therapeutic Strategies Ann Intern Med, March 4, 2003; 138(5): 400 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Pratico, C. M. Clark, F. Liun, V. Y.-M. Lee, and J. Q. Trojanowski Increase of Brain Oxidative Stress in Mild Cognitive Impairment: A Possible Predictor of Alzheimer Disease Arch Neurol, June 1, 2002; 59(6): 972 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Uryu, H. Laurer, T. McIntosh, D. Pratico, D. Martinez, S. Leight, V. M.-Y. Lee, and J. Q. Trojanowski Repetitive Mild Brain Trauma Accelerates Abeta Deposition, Lipid Peroxidation, and Cognitive Impairment in a Transgenic Mouse Model of Alzheimer Amyloidosis J. Neurosci., January 15, 2002; 22(2): 446 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Droge Free Radicals in the Physiological Control of Cell Function Physiol Rev, January 1, 2002; 82(1): 47 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Lim, T. Chu, F. Yang, W. Beech, S. A. Frautschy, and G. M. Cole The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse J. Neurosci., November 1, 2001; 21(21): 8370 - 8377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Pratico, K. Uryu, S. Leight, J. Q. Trojanoswki, and V. M.-Y. Lee Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis J. Neurosci., June 15, 2001; 21(12): 4183 - 4187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Cyrus, D. Pratico, L. Zhao, J. L. Witztum, D. J. Rader, J. Rokach, G. A. FitzGerald, and C. D. Funk Absence of 12/15-Lipoxygenase Expression Decreases Lipid Peroxidation and Atherogenesis in Apolipoprotein E-Deficient Mice Circulation, May 8, 2001; 103(18): 2277 - 2282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Meagher, O. P. Barry, J. A. Lawson, J. Rokach, and G. A. FitzGerald Effects of Vitamin E on Lipid Peroxidation in Healthy Persons JAMA, March 7, 2001; 285(9): 1178 - 1182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Lovell and W. R. Markesbery Ratio of 8-Hydroxyguanine in Intact DNA to Free 8-Hydroxyguanine Is Increased in Alzheimer Disease Ventricular Cerebrospinal Fluid Arch Neurol, March 1, 2001; 58(3): 392 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. E. Reich, W. R. Markesbery, L. J. Roberts II, L. L. Swift, J. D. Morrow, and T. J. Montine Brain Regional Quantification of F-Ring and D-/E-Ring Isoprostanes and Neuroprostanes in Alzheimer's Disease Am. J. Pathol., January 1, 2001; 158(1): 293 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wyss and R. Kaddurah-Daouk Creatine and Creatinine Metabolism Physiol Rev, July 1, 2000; 80(3): 1107 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Burke, J. A. Lawson, E. A. Meagher, J. Rokach, and G. A. FitzGerald Specific Analysis in Plasma and Urine of 2,3-Dinor-5,6-dihydro-isoprostane F2alpha -III, a Metabolite of Isoprostane F2alpha -III and an Oxidation Product of gamma -Linolenic Acid J. Biol. Chem., January 28, 2000; 275(4): 2499 - 2504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Li, J. A. Lawson, M. Reilly, M. Adiyaman, S.-W. Hwang, J. Rokach, and G. A. FitzGerald Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F2-isoprostanes in human urine PNAS, November 9, 1999; 96(23): 13381 - 13386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Montine, W. R. Markesbery, W. Zackert, S. C. Sanchez, L. J. Roberts II, and J. D. Morrow The Magnitude of Brain Lipid Peroxidation Correlates with the Extent of Degeneration but Not with Density of Neuritic Plaques or Neurofibrillary Tangles or with APOE Genotype in Alzheimer's Disease Patients Am. J. Pathol., September 1, 1999; 155(3): 863 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Lawson, J. Rokach, and G. A. FitzGerald Isoprostanes: Formation, Analysis and Use As Indices of Lipid Peroxidation in Vivo J. Biol. Chem., August 27, 1999; 274(35): 24441 - 24444. [Full Text] [PDF]
|
|
|
|
|
|
C. Barlow, P. A. Dennery, M. K. Shigenaga, M. A. Smith, J. D. Morrow, L. J. Roberts II, A. Wynshaw-Boris, and R. L. Levine Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs PNAS, August 17, 1999; 96(17): 9915 - 9919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-H. CHENG, Y. X. FU, J. M. PORRES, D. A. ROSS, and X. G. LEI Selenium-dependent cellular glutathione peroxidase protects mice against a pro-oxidant-induced oxidation of NADPH, NADH, lipids, and protein FASEB J, August 1, 1999; 13(11): 1467 - 1475. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
